Skip to main content
NCBI home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 Mar 15;10(1):166–173. doi: 10.1111/j.1582-4934.2006.tb00298.x

Ovariectomy ameliorates dextromethorphan - induced memory impairment in young female rats

Jeong Won Jahng a,*, Hee Jeong Cho a, Jae Goo Kim a, Nam Youl Kim a, Seoul Lee b, Yil Seob Lee a
PMCID: PMC3933109  PMID: 16563229

Abstract

We have previously found that dextromethorphan (DM), over-the-counter cough suppressant, impairs memory retention in water maze task, when it is repeatedly administrated to adolescent female rats at high doses. In this study we examined first if ovariectomy ameliorates the DM-induced memory impairment in female rats, and then whether or not the DM effect is revived by estrogen replacement in ovariectomized female rats. Female rat pups received bilateral ovariectomy or sham operation on postnatal day (PND) 21, and then intraperitoneal DM (40 mg/kg) daily during PND 28–37. Rats were subjected to the Morris water maze task from PND 38, approximately 24 h after the last DM injection. In probe trial, goal quadrant dwell time was significantly reduced by DM in the sham operated group, however, the reduction by DM did not occur in the ovariectomy group. When 17β-estradiol was supplied to ovariectomized females during DM treatment, the goal quadrant dwell time was significantly decreased, compared to the vehicle control group. Furthermore, a major effect of estrogen replacement was found in the escape latency during the last 3 days of initial learning trials. These results suggest that ovariectomy may ameliorate the adverse effect of DM treatment on memory retention in young female rats, and that estrogen replacement may revive it, i.e. estrogen may take a major role in DM-induced memory impairment in female rats.

Keywords: NMDA receptor, estrogen, learning and memory

References

  • 1.Bem JL, Peck R. Dextromethorphan. An overview of safety issues. Drug Safety. 1992;7:190–9. doi: 10.2165/00002018-199207030-00004. [DOI] [PubMed] [Google Scholar]
  • 2.Steinberg GK, Kunis D, de LaPaz R, Poljak A. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan has a favourable dose response profile. Neurol Res. 1993;15:174–80. doi: 10.1080/01616412.1993.11740131. [DOI] [PubMed] [Google Scholar]
  • 3.Sagratella S. NMDA antagonists: antiepileptic-neuroprotective drugs with diversified neuropharmacological profiles. Pharmacol Res. 1995;32:1–13. doi: 10.1016/s1043-6618(95)80002-6. [DOI] [PubMed] [Google Scholar]
  • 4.Price DD, Mao J, Lu J, Caruso FS, Frenk H, Mayer DJ. Effects of the combined oral administration of NSAIDs and dextromethorphan on behavioral symptoms indicative of arthritic pain in rats. Pain. 1996;68:119–27. [PubMed] [Google Scholar]
  • 5.Weinbroum AA, Rudick V, Paret G, Ben-Abraham R. The role of dextromethorphan in pain control. Can J Anaesth. 2000;47:585–96. doi: 10.1007/BF03018952. [DOI] [PubMed] [Google Scholar]
  • 6.Chase TN, Oh JD, Konitsiotis S. Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms. J Neurol. 2000;247(Suppl 2):II36–42. doi: 10.1007/pl00007759. [DOI] [PubMed] [Google Scholar]
  • 7.Fisher K, Coderre TJ, Hagen NA. Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage. 2000;20:358–73. doi: 10.1016/s0885-3924(00)00213-x. [DOI] [PubMed] [Google Scholar]
  • 8.Murray S, Brewerton T. Abuse of over-the-counter dextromethorphan by teenagers. South Med J. 1993;86:1151–3. doi: 10.1097/00007611-199310000-00014. [DOI] [PubMed] [Google Scholar]
  • 9.Wolfe TR, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med. 1995;13:174–6. doi: 10.1016/0735-6757(95)90088-8. [DOI] [PubMed] [Google Scholar]
  • 10.Darboe MN, Keenan GR, Jr, Richards TK. The abuse of dextromethorphan-based cough syrup: a pilot study of the community of Waynesboro, Pennsylvania. Adolescence. 1996;31:633–44. [PubMed] [Google Scholar]
  • 11.Noonan WC, Miller WR, Feeney DM. Dextromethorphan abuse among youth. Arch Fam Med. 2000;9:791–2. doi: 10.1001/archfami.9.9.791-a. [DOI] [PubMed] [Google Scholar]
  • 12.Zhang TY, Jahng JW, Kim D. Dextromethorphan increases tyrosine hydroxylase mRNA in the mesencephalon of adolescent rats. Neurosci Lett. 2001;309:85–8. doi: 10.1016/s0304-3940(01)02029-8. [DOI] [PubMed] [Google Scholar]
  • 13.Jahng JW, Zhang TY, Lee S, Kim D. Effects of dextromethorphan on the nocturnal behavior and brain c-Fos expressions in adolescent rats. Eur J Pharmacol. 2001;431:47–52. doi: 10.1016/s0014-2999(01)01409-1. [DOI] [PubMed] [Google Scholar]
  • 14.Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharamcol Rev. 1999;51:7–61. [PubMed] [Google Scholar]
  • 15.Price LH, Lebel J. Dextromethorphan-induced psychosis. Am J Psychiat. 2000;157:304. doi: 10.1176/appi.ajp.157.2.304. [DOI] [PubMed] [Google Scholar]
  • 16.Morris RGM, Andersen E, Lynch GS, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist AP5. Nature. 1986;319:774–776. doi: 10.1038/319774a0. [DOI] [PubMed] [Google Scholar]
  • 17.Morris RGM. Synaptic plasticity and learning. Selective impairment of learning in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist APV. J Neurosci. 1989;9:3040–3057. doi: 10.1523/JNEUROSCI.09-09-03040.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Shapiro ML, Caramanos Z. NMDA antagonist MK-801 impairs acquisition but not performance of spatial working memory and reference memory. Psychobiology. 1990;18:231–243. [Google Scholar]
  • 19.Davis S, Butcher SP, Morris GRM. The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci. 1992;12:21–34. doi: 10.1523/JNEUROSCI.12-01-00021.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.McDonald RJ, Hong NS, Craig LA, Holahan MR, Louis M, Muller RU. NMDA-receptor blockade by CPP impairs post-training consolidation of a rapidly acquired spatial representation in rat hippocampus. Eur J Neurosci. 2005;22:1201–1213. doi: 10.1111/j.1460-9568.2005.04272.x. [DOI] [PubMed] [Google Scholar]
  • 21.Gorter JA, de Bruin JPC. Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat. Brain Res. 1992;580:12–7. doi: 10.1016/0006-8993(92)90921-u. [DOI] [PubMed] [Google Scholar]
  • 22.Sircar R. Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-D-aspartate receptor upregulation. Int J Devl Neurosci. 2003;21:159–67. doi: 10.1016/s0736-5748(03)00026-1. [DOI] [PubMed] [Google Scholar]
  • 23.Bane A, Rojas D, Indermaur K, Bennett T, Avery D. Adverse effects of dextromethorphan on the spatial learning of rats in the Morris water maze. Eur J Pharmacol. 1996;302:7–12. doi: 10.1016/0014-2999(96)00056-8. [DOI] [PubMed] [Google Scholar]
  • 24.Zhang TY, Jahng JW, Kim EJ, Chung H, Kim D. Chronic dextromethorphan increases NMDAR1 immunoreactivity in the brain and induces sensitization of stereotyped behavior in female rats. Soc Neurosci Abs. 1999;25:2077. [Google Scholar]
  • 25.Cho HJ, Kim JG, Lee JY, Lee S, Jahng JW. 2005. Repetitive dextromethorphan at adolescence affects water maze learning in female rats Intl J Neurosci ; In press.
  • 26.Galea LA, Wide JK, Paine TA, Holmes MM, Ormerod BK, Floresco SB. High levels of estradiol disrupt conditioned place preference learning, stimulus response learning and reference memory but have limited effects on working memory. Behav Brain Res. 2001;126:115–26. doi: 10.1016/s0166-4328(01)00255-8. [DOI] [PubMed] [Google Scholar]
  • 27.Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci. 1990;10:1286–91. doi: 10.1523/JNEUROSCI.10-04-01286.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol. 1993;336:293–306. doi: 10.1002/cne.903360210. [DOI] [PubMed] [Google Scholar]
  • 29.Weiland NG. Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology. 1992;131:662–8. doi: 10.1210/endo.131.2.1353442. [DOI] [PubMed] [Google Scholar]
  • 30.Gazzaley AH, Weiland NG, McEwen BS, Morrison JH. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J Neurosci. 1996;16:6830–8. doi: 10.1523/JNEUROSCI.16-21-06830.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Woolley CS, Weiland NG, McEwen BS, Schwartkroin PA. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci. 1997;17:1848–59. doi: 10.1523/JNEUROSCI.17-05-01848.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Waynforth HB, Flecknell PA. Experimental and surgical technique in the rat. Academic Press; 1992. New York; [Google Scholar]
  • 33.Venable N, Kelly P. Effects of NMDA antagonists on memory processes in a novel two-trial swimming test. Behav Pharmacol. 1991;2:161–9. [PubMed] [Google Scholar]
  • 34.Willets J, Balster RL, Leander JD. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci. 1990;11:423–8. doi: 10.1016/0165-6147(90)90150-7. [DOI] [PubMed] [Google Scholar]
  • 35.Ylinen A, Pitkanen M, Sirvio J, Hartikainen T, Sivenius J, Koivisto E, Riekkinen PJ., Jr The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task. Eur J Pharmacol. 1995;274:159–65. doi: 10.1016/0014-2999(94)00729-q. [DOI] [PubMed] [Google Scholar]
  • 36.Butelman ER. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task. Pharmacol Biochem Behav. 1989;34:13–6. doi: 10.1016/0091-3057(89)90345-6. [DOI] [PubMed] [Google Scholar]
  • 37.McEwen B. Estrogen actions throughout the brain. Recent Prog Horm Res. 2002;57:357–84. doi: 10.1210/rp.57.1.357. [DOI] [PubMed] [Google Scholar]
  • 38.Pozzo-Miller LD, Inque T, Murphy DD. Estradiol increases spine density and NMDA-dependent Ca++ transientsin spines of Ca1 pyramidal neurons from hippocampal slices. J Neurophysiol. 1999;81:1404–11. doi: 10.1152/jn.1999.81.3.1404. [DOI] [PubMed] [Google Scholar]
  • 39.Foy MR, Xu J, Xie X, Brinton RD, Thompson RF, Beger TW. 17b-Estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J Neurophysiol. 1999;81:925–9. doi: 10.1152/jn.1999.81.2.925. [DOI] [PubMed] [Google Scholar]
  • 40.Holmes MM, Wide JK, Galea LAM. Low levels of estradiol facilitate, whereas high levels of estradiol impair, working memory performance on the radial arm maze. Behav Neurosci. 2002;116:928–34. doi: 10.1037//0735-7044.116.5.928. [DOI] [PubMed] [Google Scholar]
  • 41.Frick KM, Fernandez SM, Bennett JC, Prange-Kiel J, MacLusky NJ, Leranth C. Behavioral training interferes with the ability of gonadal hormones to increase CA1 spine synapse density in ovariectomized female rats. Eur J Neurosci. 2004;19:3026–32. doi: 10.1111/j.1460-9568.2004.03427.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES